Basic and diluted net loss per common share are determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. For periods in which the Company was in a net loss, the shares issuable upon conversion, exercise or vesting of Convertible Notes, warrants, stock option awards and RSUs have been excluded from the calculation because their effects would be anti-dilutive. Therefore, the weighted average common shares outstanding used to calculate both basic and diluted net loss per common share are the same.

The following potentially dilutive securities were excluded from the computation of diluted weighted average common shares outstanding due to their anti-dilutive effect:


	Six Months Ended June 30,
		2026	2025
Shares to be issued upon conversion of Convertible Notes		10,971,895	10,971,895
Restricted stock units (RSUs)		9,405,109	14,468,303
Stock Options		7,067,252	7,077,512
Warrants		125,999	5,758,536

Total anti-dilutive securities excluded from EPS computation		27,570,255	38,276,246